Sanjivani Paranteral Limited (BOM:531569)

Market Cap	2.61B
Revenue (ttm)	700.99M
Net Income (ttm)	80.94M
Shares Out	12.08M
EPS (ttm)	6.66
PE Ratio	32.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,810
Average Volume	9,249
Open	220.00
Previous Close	217.60
Day's Range	212.10 - 221.00
52-Week Range	190.00 - 396.95
Beta	-0.65
RSI	39.42
Earnings Date	Aug 13, 2025

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. It manufactures pharmaceutical products in a form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas comprising central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, topicals, nasal sprays, liquid injection, capsules, tablets, dry syrups, and ear/eye drops. The company also exports its products. Sanjivani Paranteral Limited was inco...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 33
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531569

Financial Performance

In 2024, Sanjivani Paranteral's revenue was 700.99 million, an increase of 28.83% compared to the previous year's 544.11 million. Earnings were 80.94 million, an increase of 31.29%.